The integration of the DM–AHR model into clinical workflows is therefore seen not just as a technological enhancement but as a vital tool in the fight against skin cancer, offering a blend of precision and speed that is crucial for effective medical care. The gene discussed is AHR; the disease is skin neoplasm.